Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,882
-
Share change
-
-4,728
-
Total reported value
-
$62,048
-
Price per share
-
$4.07
-
Number of holders
-
5
-
Value change
-
-$18,274
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of Xenetic Biosciences, Inc. - COM (XBIO) as of Q2 2024
As of 30 Jun 2024,
Xenetic Biosciences, Inc. - COM (XBIO) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,882 shares.
The largest 5 holders included
GEODE CAPITAL MANAGEMENT, LLC, JTC Employer Solutions Trustee Ltd, UBS Group AG, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.